These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3355894)

  • 1. A new procoagulant in acute leukemia.
    Falanga A; Alessio MG; Donati MB; Barbui T
    Blood; 1988 Apr; 71(4):870-5. PubMed ID: 3355894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer procoagulant in acute lymphoblastic leukemia.
    Alessio MG; Falanga A; Consonni R; Bassan R; Minetti B; Donati MB; Barbui T
    Eur J Haematol; 1990 Aug; 45(2):78-81. PubMed ID: 2209822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
    Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
    Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
    Falanga A; Consonni R; Marchetti M; Mielicki WP; Rambaldi A; Lanotte M; Gordon SG; Barbui T
    Leukemia; 1994 Jan; 8(1):156-9. PubMed ID: 8289480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.
    Szczepański M; Bardadin K; Zawadzki J; Pypno W
    J Cancer Res Clin Oncol; 1988; 114(5):519-22. PubMed ID: 3182913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
    De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
    Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant effects of retinoic acids on leukemia cells.
    Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
    Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
    Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
    J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
    Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
    Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteinase procoagulant from amnion-chorion.
    Gordon SG; Hasiba U; Cross BA; Poole MA; Falanga A
    Blood; 1985 Dec; 66(6):1261-5. PubMed ID: 3933592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.
    Falanga A; Iacoviello L; Evangelista V; Belotti D; Consonni R; D'Orazio A; Robba L; Donati MB; Barbui T
    Blood; 1995 Aug; 86(3):1072-81. PubMed ID: 7620161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.
    Mielicki WP; Tagawa M; Gordon SG
    Thromb Haemost; 1994 Apr; 71(4):456-60. PubMed ID: 8052963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
    Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemistry of cancer procoagulant.
    Mielicki WP
    Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines.
    Inufusa H; Adachi T; Suzuki M; Ando O; Ohta T; Kurimoto M; Nakatani Y; Nakamura M; Yasutomi M
    Cancer; 1998 Apr; 82(8):1563-9. PubMed ID: 9554535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.
    Falanga A; Shaw E; Donati MB; Consonni R; Barbui T; Gordon S
    Thromb Res; 1989 Jun; 54(5):389-98. PubMed ID: 2772865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker.
    Gordon SG; Benson B
    Thromb Res; 1989 Nov; 56(3):431-40. PubMed ID: 2617480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.